Send feedback

MAP2K3 p.Arg96Trp

c.286C>T · VCV3891623

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.905 · ACMG-weighted
gnomAD v4.1
Common
common (popmax 50%, amr) — too common for a highly-penetrant pathogenic allele
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL indeterminate
Conditions
1
MAP2K3-related disorder

Computational evidence

Protein change
AlphaMissense0.905likely pathogenic
REVEL0.375indeterminate
SaProtLLR -12.98damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL is indeterminate.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 6GERP 2.4, phastCons 1
Regional constrainto/e 1.07unconstrained · MANE · 20 kb · p 0.26 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 50% Admixed American · 29,842/59,702 alleles
Filtering AF 49.7% ClinGen BA1/BS1 input FAF95, joint · FAF99 49.7%
Overall 49.9% 771,864/1,548,344 alleles · common exomes 695,652/1,395,920 · genomes 76,212/152,424 · joint denominator
Ancestry group Frequency 1 in
Amishnot grpmax-eligible 50% 2
Admixed Americangrpmax 50% 2
Finnishnot grpmax-eligible 50% 2
Middle Eastern 50% 2
East Asian 50% 2
South Asian 49.9% 2
Ashkenazi Jewishnot grpmax-eligible 49.9% 2
African / African-American 49.9% 2
Remaining individualsnot grpmax-eligible 49.9% 2
European (non-Finnish) 49.8% 2

Amish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
MAP2K3
Protein
p.Arg96Trp
Coding
c.286C>T
MANE Select
NM_145109
Type
single nucleotide variant
Location
chr17:21300880 (GRCh38)
Gene constraint
LOEUF 0.993 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 81.13
Residue 96
the protein kinase domain; a UniProt-annotated variant site (in)
Full MAP2K3 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

MAP2K3-related disorder

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/map2k3-p-arg96trp (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown